Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Rankning i aktier #31190
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Aktiekurs
$0.03808538
Marknadsvärde
$14.04M
Förändring (1 dag)
-3.57%
Förändring (1 år)
6.63%
Land
AU
Handel BCAL Diagnostics Limited (BDX)

Kategori

Historik för aktiesplit för BCAL Diagnostics Limited (BDX)
Aktien BCAL Diagnostics Limited (symbol: BDX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 18, 2026.
En BDX-aktie köpt före Aug 18, 2026 motsvarar nu 0 BDX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US